- 8 things you need to know about the BA.3.2 ‘Cicada’ variant of COVID-19
- Zimbabwean Company Launches Drone Technology to Deliver Medicines and Blood Products
- Two LGBTIQ-Linked Zim NGOs Rejected Under New PVO Decisions
- Egyptian Cardiothoracic Surgeons Lead Zimbabwe’s Third Paediatric Heart Surgery Mission
- Burundi mystery outbreak remains unsolved after More Than 200 pathogen tests
Zimbabwe Ranks Second Globally for HIV-Related Stigma, UNAIDS Report Finds
By Kuda Pembere Zimbabwe has the second highest proportion of people who experienced HIV-related stigma while seeking HIV or other health services in the past year, according to the latest UNAIDS report. Drawing from the People Living with HIV Stigma Index 2.0 (2020–2024), the UNAIDS Global AIDS Update 2025 shows that Iran tops the list
Read More
NAC Fears HIV Setbacks Despite Global Praise
By Michael Gwarisa Zimbabwe has earned international praise for its HIV response, with the latest UNAIDS Global AIDS Update 2025 placing the country among a select group on track to meet the ambitious 2030 target of ending AIDS as a public health threat. However, health authorities at home have issued a stark warning: the next
Read MoreGilead’s Secrecy Over HIV Prevention Shot Sparks Global Outrage
By Staff Reporter Gilead Sciences has come under fire after announcing a secretive deal to supply its long-acting injectable HIV prevention drug, lenacapavir (LEN-LA), to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The agreement—shrouded in indefinite price secrecy—has been widely condemned by civil society organisations, health advocates, and global health experts who warn
Read MoreNational AIDS Council Holds 2023 AGM, Sets Sights on 2030 HIV Targets
By Michael Gwarisa The National AIDS Council (NAC) on Thursday held its long-awaited Annual General Meeting (AGM) for 2023, following a year-long hiatus after the dissolution of the previous board. The AGM, which had been delayed throughout 2024, marked a significant turning point in NAC’s operations as the newly appointed board seeks to restore momentum
Read MoreTablets and Tenacity: How Young HIV Peer Supporters Are Transforming Treatment Adherence in Rural Zimbabwe
By Michael Gwarisa in Gutu Every morning, 20-year-old Christin Madombi wakes up with a mission. From her modest home in Gutu’s Mutero area, she powers up her tablet and scans through a list of peers—young people just like her, living with HIV. She has 24 peers assigned to her under the Community Adolescent Treatment Supporter
Read MoreSuspended HIV Services Resume in Masvingo as CAB-LA, Vaginal Ring Return for Key Populations
By Michael Gwarisa, recently in Masvingo For the past 12 months, Wellington*, a 41-year-old Masvingo man who has sex with men (MSM) and a male sex worker, has relied on oral Pre-Exposure Prophylaxis (PrEP) to reduce his risk of HIV infection. He has also used condoms and occasionally Post-Exposure Prophylaxis (PEP). At the start of
Read MoreFDA approves twice-a-year injection for HIV prevention
CNN — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.
Read MoreHow Masvingo’s Health Facilities Are Giving Sex Workers a Lifeline Amid Donor Cuts
By Michael Gwarisa in Masvingo She is nine months pregnant and could give birth any day now, yet Melody Mhlanga* still sells sex to survive. The 25-year-old from Gutu, Masvingo Province, found herself thrust into the world of sex work three months ago after her marriage collapsed. With no income, no support, and a baby
Read MoreZimbabwe’s NAC Boosts Lifesaving Kidney Care for People Living with HIV
By Michael Gwarisa In a landmark move, the National AIDS Council (NAC) has stepped in to support Zimbabwe’s growing renal care burden, particularly for People Living with HIV (PLHIV), by funding essential dialysis services at Parirenyatwa Hospital. The intervention comes amid growing concern about the hidden epidemic of kidney failure among people on lifelong antiretroviral
Read More“I’ll Fix It”: Elon Musk Responds to Outcry Over Lenacapavir Funding Halt
By Michael Gwarisa Billionaire Elon Musk, who also serves as an advisor to United States President Donald Trump, has hinted at intervening in the ongoing funding crisis affecting global HIV programs—particularly the rollout of Lenacapavir, a groundbreaking once-a-year HIV prevention drug. Musk made the remarks during a conversation with Bloomberg’s Mitchell Hussein at the Qatar
Read More